Matthew S Block, MD, PhD

  • 882 Citations
  • 17 Scopus h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Matthew S Block is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Biomarkers Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 882 Citations
  • 17 Scopus h-Index
  • 52 Article
  • 1 Chapter
  • 1 Comment/debate
  • 1 Letter

Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine

Vera, J., Paludo, J., Kottschade, L., Brandt, J., Yan, Y., Block, M. S., Mc Williams, R. R., Dronca, R. S., Loprinzi, C. L., Grothey, A. F. & Markovic, S. N., Jan 1 2019, In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Colchicine
Fever
Mitogen-Activated Protein Kinases
Familial Mediterranean Fever
Therapeutics
1 Citation (Scopus)

Immune checkpoint inhibitors: An emerging cause of insulin-dependent diabetes

Kotwal, A., Haddox, C., Block, M. S. & Kudva, Y. C., Feb 1 2019, In : BMJ Open Diabetes Research and Care. 7, 1, e000591.

Research output: Contribution to journalArticle

Insulin
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Programmed Cell Death 1 Receptor
Diabetic Ketoacidosis
1 Citation (Scopus)

The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy

Cannon, M. J., Block, M. S., Morehead, L. C. & Knutson, K. L., Feb 1 2019, In : Immunotherapy. 11, 2, p. 75-79 5 p.

Research output: Contribution to journalComment/debate

Cancer Vaccines
Glioblastoma
Pancreatic Neoplasms
Acute Myeloid Leukemia
Ovarian Neoplasms

The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma

Kumar, A. B., Aguilera, J. V., Velazquez, A., Yan, Y., Jakub, J. W., Brewer, J., Hieken, T. J., Block, M. S., Mc Williams, R. R., Otley, C., Markovic, S. N. & Kottschade, L., Jan 1 2019, In : Dermatologic Therapy. e12813.

Research output: Contribution to journalLetter

L-Lactate Dehydrogenase
Melanoma
Serum
6 Citations (Scopus)

Folate receptor alpha peptide vaccine generates immunity in breast and ovarian cancer patients

Kalli, K. R., Block, M. S., Kasi, P. M., Erskine, C. L., Hobday, T. J., Dietz, A. B., Padley, D., Gustafson, M. P., Shreeder, B., Puglisi-Knutson, D., Visscher, D. W., Mangskau, T. K., Wilson, G. & Knutson, K. L., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3014-3025 12 p.

Research output: Contribution to journalArticle

Folate Receptor 1
Subunit Vaccines
Ovarian Neoplasms
Immunity
Breast Neoplasms